3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3H-benzooxazol-2-one
Intermediate
IntermediateConfidentiality：Public
- INN / Generic Name
- 3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3H-benzooxazol-2-one
- CAS No.
- 1220696-32-1
- Current Status
- Official intermediate catalog (API: Brensocatib)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
Formulation & registration fields (API/FDF oriented — tap to expand)
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Brensocatib
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO supply (non-registered substance)
HS Code
2933.591100 customs bills on file
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- Intermediate #5 of Route 1 (14 steps) for Brensocatib. Route materials include: 1802148-05-5, 2-amino-4-chlorophenol, 5-chlorobenzo[d]oxazol-2(3H)-one, 5-chloro-3-methylbenzo[d]oxazol-2(3H)-one, tert-butyl (S)-(1-amino-3-(4-iodophenyl)-1-oxopropan-2-yl)carbamate, tert-butyl (S)-(1-amino-3-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)-1-oxopropan-2-yl)carbamate, (S)-2-amino-3-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)propanamide, (S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid. Source: Pharmacodia route data (in-house patent-cliff DB); full step sequence via SciFinder / Google Patents.Synthesis route auto-filled from in-house Pharmacodia route data — verify full steps on SciFinder / Google Patents.
- Exact Price